Dr. Goldman is an Associate Professor of Pediatrics in the Divisions Pediatric Infectious Diseases and Clinical Pharmacology at Children’s Mercy Kansas City. She serves as the Director of the Antimicrobial Stewardship Program at Children’s Mercy. The overarching goal of the program is to optimize antibiotic therapy by providing guidance on how to best use antibiotics throughout the hospital.

Dr. Goldman’s primary research focus is adverse drug reactions. She is investigating potential biomarkers that may predict and prevent severe adverse drug reactions. Her long-term goal is to individualize therapeutic treatment in children so that unintended consequences of medications can be avoided. Her research has been funded by the National Institutes of Health, Kansas City Area Life Sciences Institute, and the Marion Merrell Dow Clinical Scholars Award. She currently serves as the Pediatric Health Organization Representative on the Pediatric Advisory Committee for the Food and Drug Administration.

Dr. Goldman is a Kansas City native. After spending two years in Central Africa as a Peace Corps volunteer, she spent time in New York working at the Arthritis Foundation. She then returned to Kansas City to attend medical school at Kansas University Medical Center. She completed pediatric residency and a combined pediatric infectious diseases and clinical pharmacology fellowship at Children’s Mercy.